Evidence and reality: an observational study on pharmacological outcomes in advanced head and neck tumors by Consuelo Jordán de Luna, Consuelo Jordán de Luna, Anna Esteve, Olalla Montero Pérez, Ana Clopés Estela, Ana Clopés Estela, Marc Oliva, Alicia Lozano Borbalas, Ricard Mesía Nin

Get full text

Correction: Evidence and reality: an observational study on pharmacological outcomes in advanced head and neck tumors by Consuelo Jordán de Luna, Consuelo Jordán de Luna, Anna Esteve, Olalla Montero Pérez, Ana Clopés Estela, Ana Clopés Estela, Marc Oliva, Alicia Lozano Borbalas, Ricard Mesía Nin

Get full text

Nintedanib in combination with docetaxel for second-line treatment of advanced non-small-cell lung cancer; GENESIS-SEFH drug evaluation report by María Espinosa Bosch, Rocío Asensi Diez, Sara García Agudo, Ana Clopes Estela

Get full text

Survey of oncohematological pharmaceutical care situation in Spain by María José Martínez-Bautista, Irene Mangues-Bafalluy, Gerardo Cajaraville-Ordoñana, María Josep Carreras-Soler, Ana Clopés-Estela, Estela Moreno-Martínez

Get full text

DPYD Genotyping, Fluoropyrimidine Dosage and Toxicity: An Umbrella Review of Systematic Reviews by Sara Otero-Torres, Rosa Rodríguez-Mauriz, Eduard Fort-Casamartina, Ana Clopés-Estela, Francesc Soler-Rotllant, Sandra Fontanals-Martínez, Olalla Montero-Pérez

Get full text